RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment

J Natl Cancer Inst. 2015 Feb 6;107(3):dju509. doi: 10.1093/jnci/dju509. Print 2015 Mar.

Authors

Jason Adhikaree¹, Yvette Newby², Santhanam Sundar²

Affiliations

¹ Academic Oncology Department, Nottingham City Hospital, Nottingham, UK (JA, YN, SS). jadhikaree@doctors.org.uk.
² Academic Oncology Department, Nottingham City Hospital, Nottingham, UK (JA, YN, SS).

PMID: 25663690
DOI: 10.1093/jnci/dju509

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Bone Density Conservation Agents / therapeutic use*
Bone Neoplasms / complications*
Diphosphonates / therapeutic use*
Female
Humans
Hypercalcemia / drug therapy*
Hypercalcemia / etiology*
Male

Substances

Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents
Diphosphonates